InvestorsHub Logo
Followers 971
Posts 383012
Boards Moderated 6
Alias Born 06/24/2011

Re: None

Thursday, 05/17/2018 12:35:50 PM

Thursday, May 17, 2018 12:35:50 PM

Post# of 6013
Company growth strategy includes the development of CBD pharmaceutical drugs, expanding its portfolio of CBD brands and aggressively continuing its international expansion in Latin America, Asia and Europe. https://m.nasdaq.com/press-release/isodiol-receives-government-approval-for-pure-natural-cbd-as-an-active-pharmaceutical-ingredient-20180426-01246

$ISOLF $ISOL

(CSE: ISOL) (OTC: ISOLF)